deaths from glp 1 Glucagon-like peptide-1 receptor agonists and risk of suicidality among patients with type 2 diabetes: active comparator, new user cohort study The letter cited three deaths

No fear about what happens if they go away

Signs you may not be getting enough include unusual fatigue, hair loss, dry or itchy skin, muscle weakness, slow healing, or easy bruising

This review examines a broad spectrum of endogenous peptidereceptor systems that regulate metabolism, appetite, bonemusclefat crosstalk, neuroendocrine function, immune modulation, and tissue repair, yet lack approved therapeutic analogs

J Enzyme Inhibition Med Chem 20(1): 69-74

Knowing those two things alone, it is sensible to be more prudent with the use of this drug, with consideration of coincident toxin exposures and of susceptibility